Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depigmented and Polymerised Allergenic Extract of D. Pteronyssinus for Allergic Asthma
NCT00622362Phase 2Terminated
- Sponsor
- LETI Pharma
- Start
- Jan 2008
- Primary completion
- Feb 2009
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of dermatophagoides pteronyssinus in allergic asthma, sponsored by LETI Pharma. Started Jan 2008; status: terminated.
02
Drugs
dermatophagoides pteronyssinus
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00622362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622362.